The Asia-Pacific pharmaceutical analytical testing outsourcing market is estimated to grow at a CAGR of around 9.5% during the forecast period. The market is mainly growing due to the significant migration of major pharmaceutical companies across the globe towards China, and India for pharmaceutical outsourcing services. Moreover, growing pharmaceutical manufacturing coupled with the rising number of chronic diseases in the region further provide the opportunity in near future. The Asia-Pacific market for pharmaceutical analytical testing outsourcing is classified on the basis of product type and services.
Based on the product type, the market is further classified into API, raw materials, and finished products. The API segment is projected to have considerable growth during the forecast period. Based on the services, the Asia-Pacific pharmaceutical analytical testing outsourcing market is further segmented into Bioanalytical services, stability testing, drug substance, method development & validation, and others. Geographically, the Asia-Pacific pharmaceutical analytical testing outsourcing market is further classified into China, India, Japan, and the Rest of Asia-Pacific. Among these countries, China is anticipated to hold a significant market share in the Asia-Pacific pharmaceutical analytical testing outsourcing market.
Furthermore, the Asia-Pacific pharmaceutical analytical testing outsourcing market is characterized by the presence of several market players that are catering to a wide range of customers across the globe. Some of the key players in the market include Charles River Laboratories International, Inc., CMIC, Inc, Cambrex Corp., Covance Inc., Dalton Pharma Services, WuXi AppTec Co., Ltd., and others. These players adopt various strategies to remain competitive in the market and gain a competitive advantage over other players operating in the market. Mergers and acquisitions, product launches, and partnerships and collaborations, and geographical expansion are some of the major activities adopted by the market players.
Research Methodology
The market study of the Asia-Pacific pharmaceutical analytical testing outsourcing market is incorporated by extensive primary and secondary research conducted by the research team. Secondary research has been conducted to refine the available data to breakdown the market into various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior, and macro-economic factors. Numbers extracted from Secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings authenticity to our reports.
Secondary Sources Include
The report is intended for pharmaceutical analytical testing outsourcing market players, pharmaceutical manufacturers, contract manufacturers, distributors & traders, industry associates & experts, government organizations, regulatory bodies, and other market participants for the overall market and competitive analysis. The report provides an in-depth analysis of market size, products offered by the companies, and future market opportunities. The report will serve as a source for 360-degree analysis of the market thoroughly delivering insights into the market for making better business decisions.
Market Segmentation
The Report Covers
1. Report Summary
1.1. Research Methods and Tools
• Current Industry Analysis and Growth Potential Outlook
• Impact of COVID-19 on the Asia-Pacific Pharmaceutical Analytical Testing OutsourcingIndustry
• Recovery Scenario of the Asia-Pacific Pharmaceutical Analytical Testing OutsourcingIndustry
1.2. Market Breakdown
1.2.1. By Segments
1.2.2. By Geography
2. Market Overview and Insights
2.1. Scope of the Report
2.2. Analyst Insight & Current Market Trends
2.2.1. Key Findings
2.2.2. Recommendations
2.2.3. Conclusion
2.3. Rules & Regulations
3. Competitive Landscape
3.1. Key Company Analysis
3.1.1. Overview
3.1.2. Financial Analysis
3.1.3. SWOT Analysis
3.2. Key Strategy Analysis
3.3. Impact of COVID-19 on key players
4. Market Determinants
4.1. Motivators
4.2. Restraints
4.3. Opportunities
5. Market Segmentation
5.1. Asia-Pacific Pharmaceutical Analytical Testing Outsourcing Market by Product type
5.1.1. API
5.1.2. Raw Materials
5.1.3. Finished products
5.2. Asia-Pacific Pharmaceutical Analytical Testing Outsourcing Market by Services
5.2.1. Bioanalytical services
5.2.2. Stability testing
5.2.3. Drug substance
5.2.4. Method development & Validation
5.2.5. Others (Quality Testing)
6. Regional Analysis
6.1. China
6.2. Indian
6.3. Japan
6.4. Rest of Asia-pacific
7. Company Profiles
7.1. Charles River Laboratories International, Inc.
7.2. CMIC, Inc
7.3. Cambrex Corp.
7.4. Covance Inc.
7.5. Dalton Pharma Services
7.6. Eurofins GSC Lux SARL
7.7. KCAS Bioanalytical Services
7.8. SGS SA
7.9. Toxikon Corp.
7.10. WuXiAppTec Co., Ltd.
1. ASIA-PACIFIC PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET RESEARCH AND ANALYSIS BYPRODUCT TYPE, 2020-2027 ($ MILLION)
2. ASIA-PACIFIC API MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2020-2027 ($ MILLION)
3. ASIA-PACIFIC RAW MATERIALS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2020-2027 ($ MILLION)
4. ASIA-PACIFIC FINISHED PRODUCTS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2020-2027 ($ MILLION)
5. ASIA-PACIFIC PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET RESEARCH AND ANALYSIS BY SERVICES, 2020-2027 ($ MILLION)
6. ASIA-PACIFIC BIO ANALYTICAL SERVICES MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2020-2027 ($ MILLION)
7. ASIA-PACIFIC STABILITY TESTING MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2020-2027 ($ MILLION)
8. ASIA-PACIFIC DRUG SUBSTANCE MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2020-2027 ($ MILLION)
9. ASIA-PACIFIC METHOD DEVELOPMENT & VALIDATION MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2020-2027 ($ MILLION)
10. ASIA-PACIFIC OTHERS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2020-2027 ($ MILLION)
11. ASIA-PACIFIC PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2020-2027 ($ MILLION)
12. CHINA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET RESEARCH AND ANALYSIS BYPRODUCT TYPE, 2020-2027 ($ MILLION)
13. CHINA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET RESEARCH AND ANALYSIS BY SERVICES, 2020-2027 ($ MILLION)
14. INDIAN PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET RESEARCH AND ANALYSIS BYPRODUCT TYPE, 2020-2027 ($ MILLION)
15. INDIAN PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET RESEARCH AND ANALYSIS BY SERVICES, 2020-2027 ($ MILLION)
16. JAPAN PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET RESEARCH AND ANALYSIS BY PRODUCT TYPE, 2020-2027 ($ MILLION)
17. JAPAN PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET RESEARCH AND ANALYSIS BY SERVICES, 2020-2027 ($ MILLION)
18. REST OF ASIA-PACIFIC PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET RESEARCH AND ANALYSIS BY PRODUCT TYPE, 2020-2027 ($ MILLION)
19. REST OF ASIA-PACIFIC PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET RESEARCH AND ANALYSIS BY SERVICES, 2020-2027 ($ MILLION)
1. IMPACT OF COVID-19 ON ASIA-PACIFIC PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET, 2020-2027 (% MILLION)
2. IMPACT OF COVID-19 ON ASIA-PACIFIC PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET BY SEGMENT, 2020-2027 (% MILLION)
3. RECOVERY OF ASIA-PACIFIC PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET, 2020-2027 (%)
4. ASIA-PACIFIC PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SHARE BYPRODUCT TYPE, 2020 VS 2027 (%)
5. ASIA-PACIFIC API ANALYTICAL TESTING OUTSOURCING MARKET SHARE BY COUNTRY, 2020 VS 2027 (%)
6. ASIA-PACIFIC RAW MATERIALS ANALYTICAL TESTING OUTSOURCING MARKET SHARE BY COUNTRY, 2020 VS 2027 (%)
7. ASIA-PACIFIC FINISHED PRODUCTS ANALYTICAL TESTING OUTSOURCING MARKET SHARE BY COUNTRY, 2020 VS 2027 (%)
8. ASIA-PACIFIC PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCINGMARKET SHARE BY SERVICES, 2020 VS 2027 (%)
9. ASIA-PACIFIC BIOANALYTICAL SERVICES MARKET SHARE BY COUNTRY, 2020 VS 2027 (%)
10. ASIA-PACIFIC STABILITY TESTING MARKET SHARE BY COUNTRY, 2020 VS 2027 (%)
11. ASIA-PACIFIC DRUG SUBSTANCE MARKET SHARE BY COUNTRY, 2020 VS 2027 (%)
12. ASIA-PACIFIC PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SHARE BY COUNTRY, 2020 VS 2027 (%)
13. CHINA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, 2020-2027 ($ MILLION)
14. INDIAN PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, 2020-2027 ($ MILLION)
15. JAPAN PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, 2020-2027 ($ MILLION)
16. REST OF ASIA-PACIFIC PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, 2020-2027 ($ MILLION)